Prevalence of treated patients with Alzheimer's disease: current trends and COVID-19 impact.

ABSTRACT:

Background

There are few updated studies on the prevalence and management of Alzheimer's disease (AD), which could be underdiagnosed or undertreated. The COVID-19 pandemic may have worsened the deficiencies in the diagnosis and treatment of these patients. Electronic medical records (EMR) offer an opportunity to assess the impact and management of medical processes and contingencies in the population.

Objective

To estimate AD prevalence in Spain over a 6-year period, based on treated patients, according to usual clinical practice. Additionally, to describe the management of AD-treated patients and the evolution of that treatment during the 2020 COVID-19 pandemic.

Methods

Retrospective study using the Spanish IQVIA EMR database. Patients treated with donepezil, galanta

SUBMITTER: Olazaran J 

PROVIDER: S-EPMC10401753 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature